IGF-1 LR3 Peptide is a premium research peptide developed exclusively for scientific investigations involving insulin-like growth factor (IGF) signaling, receptor biology, cellular communication, and molecular endocrinology. As a modified analogue of insulin-like growth factor-1 (IGF-1), IGF-1 LR3 has been extensively studied because of its altered molecular structure and prolonged stability in laboratory research compared with native IGF-1.

Manufactured under strict quality-controlled conditions, every batch undergoes analytical verification using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm identity, purity, and consistency. The peptide is supplied as a sterile lyophilized powder to support stability during storage and laboratory preparation.

Researchers utilize IGF-1 LR3 Peptide to investigate growth factor signaling pathways, receptor interactions, protein expression, cellular physiology, and molecular mechanisms associated with insulin-like growth factor biology. Certificates of Analysis (COA) and supporting analytical documentation are available upon request.

For laboratory research use only. This product is not intended for human consumption, therapeutic use, veterinary applications, or diagnostic procedures.